Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation
Company Logo

Destroying Cancer at the Speed of Light®

Clinical Study Underway (75 of 100 Patients Treated)
Expected to complete enrollment at the end of 2024
Expected to complete study at the end of 2026


Bullboard - Investor Discussion Forum Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called... see more

TSXV:TLT - Post Discussion

Theralase Technologies Inc. > Short [paid promotional message] Interview with Roger
View:
Post by Eoganacht on Aug 16, 2024 11:52am

Short [paid promotional message] Interview with Roger

Comment by Oilminerdeluxe on Aug 16, 2024 2:59pm
The CC on Wednesday will have a few eyes and ears on it. Hopefully not too boring. 
Comment by TimboBaggins on Aug 16, 2024 4:36pm
  just over 600 views. We truley are unknown.  If this blows up like we all hope, we will of had 10 years worth of getting in on the ground floor. I might even be in P2 or P3
Comment by toade1313 on Aug 16, 2024 9:22pm
Yes we may be unknown but for every buyer there is a seller. A seller is someone who is KNOWN  and wants to get rid of the stock they know about. Something else is at play and I won't even try to guess what it is.
Comment by ChemVan9094 on Aug 17, 2024 10:39am
It's now over 800 views ... slow, yes, slow but steady... we're getting there ...  GLTA 
Comment by CancerSlayer on Aug 17, 2024 6:09pm
I thought is was a very good interview.  I must have watched it a hundred times...
Comment by Alamir1111 on Aug 18, 2024 4:34pm
There is another rdw interview  https://youtu.be/urlcy5M_vqs?si=QV8zY-bokzkGdXLk
Comment by Alamir1111 on Aug 18, 2024 4:40pm
https://youtu.be/Gv4zmV5ve7s?si=dPYcdMYJBX47juuPhttps://youtu.be/Gv4zmV5ve7s?si=dPYcdMYJBX47juuP
Comment by Alamir1111 on Aug 18, 2024 5:00pm
Ithink it's worth. 80 c  takeover for bp.
Comment by Alamir1111 on Aug 18, 2024 5:20pm
All emails pr nr guess another pp is coming up?
Comment by tdon1229 on Aug 19, 2024 9:11am
The previous pp remains open with only the first tranche having been obtained, but the company can't enroll and treat 10 more patients or open 5 more clinical sites w/o more money.   The warrants remain on track to expire at the end of this month rather than be exercised to replenish the company coffers.   No shelf offering has been approved, so debt financing doesn't appear ...more  
Comment by Pandora on Aug 19, 2024 10:14am
In case there are others as slow or as dumb as me: What is the meaning of deus ex machina?     deus ex machina, a person or thing that appears or is introduced into a situation suddenly and unexpectedly and provides an artificial or contrived solution to an apparently insoluble difficulty.Aug 2, 2024
Comment by 3Crows on Aug 19, 2024 10:55am
Translation: God in the machine. Often used regarding bad film scripts; rather than a rational plot device, something almost supernatural comes in to save the day.
Comment by toade1313 on Aug 18, 2024 5:45pm
Going forward please don't post these old videos without stating that they are very old videos. This one talks of 3rd qtr 2023 results and filing preBTD in 1st qtr 2024.
Comment by Alamir1111 on Aug 18, 2024 5:54pm
filing preBTD in 1st qtr 2024. Man I missed that so what happened?
Comment by toade1313 on Aug 18, 2024 6:15pm
It still hasn't happened.
Comment by toade1313 on Aug 18, 2024 5:36pm
This was older video when only 63 patients were treated.
Comment by wildbird1 on Aug 20, 2024 9:09am
Thank's Eoganacht...Great video... At the 3.37 time R.Dumoulin said. '' Our duration of response(44%CR at 450 days), has been above and superior to any FDA approved drugs''. He didn't say superior to some FDA approved drugs. No! He said superior to any (all) FDA approved drugs. Wow! You have to wonder what will be the $value of a big pharma deal, for a treatment(TLT ...more  
Comment by Oilminerdeluxe on Aug 20, 2024 9:44am
Late September, I hope to have some new funds available for Theralase shares. Wait for BTD until then, Roger.
Comment by Gooseybear on Aug 20, 2024 1:56pm
Roger should choose his words wisely based on his past experiences.
Comment by toade1313 on Aug 20, 2024 2:40pm
And I sure hope it's Roger speaking not MP (based on his last conference call).
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.


Connect with V.TLT



Investor Presentation

The Road to Saving Lives: Clinical Study Underway

  • Clinical Study with 75 of 100 Patients Treated (Enrollment to be completed by end of 2024, with study completed by end of 2026)
     
  • Ground Floor Investment Opportunity in Multi-Billion Dollar Industry
     
  • Best-in-class treatment for NMIBC (according to interim clinical data)
     
  • NMIBC (Non-Muscle-Invasive Bladder Cancer)
     

FACT SHEET

View the Presentation

The Watchlist

The Watchlist
{{currentVideo.videoCaption}}
< Previous Video {{moreVideoText}} Next Video >

Investment Opportunity

The Road to Saving Lives: Clinical Study Underway

  • Clinical Study with 72 of 100 Patients Treated (Enrollment to be completed by end of 2024, with study completed by end of 2026)
     
  • Ground Floor Investment Opportunity in Multi-Billion Dollar Industry
     
  • Best-in-class treatment for NMIBC (according to interim clinical data)
     
  • NMIBC (Non-Muscle-Invasive Bladder Cancer)
     

Facebook

Contact Us

Address:
41 Hollinger Road
Toronto, ON M4B 3G4
Canada

Toll Free:
1-866-THE-LASE (843-5273)
Local Phone:
416-699-LASE (5273)

Email:
info@theralase.com

Fax:
416-699-5250